Ironwood Pharmaceuticals Inc Working Capital to Net Assets Ratio
Ironwood Pharmaceuticals Inc working capital to net assets ratio. Ironwood Pharmaceuticals Inc (IRWD) has a Working Capital to Net Assets ratio of -102.8% as of June 2026. Working capital of $166.35 Million (current assets of $199.20 Million minus current liabilities of $32.85 Million) is measured against net assets of $-161.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Ironwood Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ironwood Pharmaceuticals Inc (2007–2025)
Working capital to net assets ratio of Ironwood Pharmaceuticals Inc from 2007 to 2025. This chart shows how Ironwood Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at -102.8%, reflecting working capital of $166.35 Million against net assets of $-161.84 Million USD. See Ironwood Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Ironwood Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2007–2025)
Ironwood Pharmaceuticals Inc working capital to net assets ratio by year from 2007 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Ironwood Pharmaceuticals Inc from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Ironwood Pharmaceuticals Inc (IRWD) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -12.2% | $31.96 Million | $-261.83 Million | $274.18 Million | $242.22 Million | ▲ +35.4 pp |
| 2024 | -47.6% | $143.52 Million | $-301.33 Million | $182.37 Million | $38.85 Million | ▼ -60.0 pp |
| 2023 | 12.4% | $-42.81 Million | $-346.30 Million | $233.29 Million | $276.10 Million | ▼ -103.4 pp |
| 2022 | 115.7% | $755.10 Million | $652.38 Million | $780.63 Million | $25.52 Million | ▲ +19.4 pp |
| 2021 | 96.3% | $583.53 Million | $605.91 Million | $745.23 Million | $161.70 Million | ▼ -643.9 pp |
| 2020 | 740.2% | $463.67 Million | $62.64 Million | $495.84 Million | $32.17 Million | ▲ +1025.4 pp |
| 2019 | -285.2% | $265.92 Million | $-93.25 Million | $306.85 Million | $40.93 Million | ▼ -210.4 pp |
| 2018 | -74.8% | $146.91 Million | $-196.37 Million | $266.44 Million | $119.52 Million | ▼ -2568.4 pp |
| 2017 | 2493.6% | $245.57 Million | $9.85 Million | $311.60 Million | $66.03 Million | ▲ +2060.3 pp |
| 2016 | 433.3% | $289.05 Million | $66.72 Million | $380.18 Million | $91.13 Million | ▼ -12.2 pp |
| 2015 | 445.5% | $423.74 Million | $95.12 Million | $500.20 Million | $76.47 Million | ▲ +186.6 pp |
| 2014 | 258.8% | $229.19 Million | $88.55 Million | $289.73 Million | $60.54 Million | ▼ -233.2 pp |
| 2013 | 492.1% | $188.09 Million | $38.23 Million | $229.13 Million | $41.04 Million | ▲ +402.2 pp |
| 2012 | 89.9% | $129.50 Million | $144.05 Million | $184.44 Million | $54.94 Million | ▼ -3.3 pp |
| 2011 | 93.2% | $102.43 Million | $109.86 Million | $167.57 Million | $65.13 Million | ▼ -28.8 pp |
| 2010 | 122.0% | $194.65 Million | $159.55 Million | $259.07 Million | $64.43 Million | ▲ +147.1 pp |
| 2009 | -25.1% | $75.01 Million | $-298.34 Million | $131.45 Million | $56.44 Million | ▲ +4.8 pp |
| 2008 | -29.9% | $68.93 Million | $-230.41 Million | $108.09 Million | $39.15 Million | ▲ +20.1 pp |
| 2007 | -50.0% | $89.24 Million | $-178.37 Million | $119.17 Million | $29.93 Million | — |